Abstract:
The invention relates to a method for the production of 1,5-naphthalenediamine and the intermediates obtained in the course of said synthesis, 4-(2-nitrophenyl)-butyronitrile, 5-nitro-3,4-dihydro-1(2H)-naphthylimine, 5-nitroso-1-naphthylamine, 5-nitro-1-naphthylamine, 4-(2-aminophenyl)-butyronitrile, 5-amino-3,4-dihydro-1(2H)-naphthalenimine, ethyl 4-(2-nitrophenyl)-butyrate and 4-(2-nitrophenyl)-butyramide.
Abstract:
Compound having general formula (I) wherein one of X and Y is CH2 and the other one is CH2, O or S; R is an aliphatic hydrocarbon group, arylalkyl, acyl, a sulphonyl group, a carbonate group or R R NCO- where R and R are selected form hydrogen and a hydrocarbon group; R is hydrogen or a hydrocarbon group; R -R are independently selected from hydrogen, halogen, alkyl, alkoxy, alkylthio, hydroxy, alkylsulphonyl, cyano, trifluoromethyl, cycloalkyl, cycloalkylalkyl or nitro; R and R are each hydrogen or lower alkyl or they are linked together to constitute a carbocyclic ring; R and R are independently hydrogen, a hydrocarbon group or a group 1a wherein R is hydrogen, or a hydrocarbon group, W is O or S, and r is 2-6; R and R are linked together thereby forming alkylene group; have effect at central 5-HT1A receptors and are useful in the treatment of psychosis, anxiety disorders, depression, impulse control disorders, alcohol abuse, aggression, ischaemic diseases, side effects induced by conventional antipsychotic agents or cardiovascular disorders.
Abstract translation:具有通式(I)的化合物,其中X和Y中的一个是CH 2,另一个是CH 2,O或S; R 1是脂族烃基,芳基烷基,酰基,磺酰基,碳酸酯基或R 11 R 12 NCO-,其中R 11和R 12选自氢和烃基 ; R 2是氢或烃基; R 3 -R 5独立地选自氢,卤素,烷基,烷氧基,烷硫基,羟基,烷基磺酰基,氰基,三氟甲基,环烷基,环烷基烷基或硝基; R 6和R 7各自为氢或低级烷基,或它们连接在一起构成碳环; R 8和R 9独立地是氢,烃基或其中R 13是氢的烃基,或者烃基,W是O或S,r是2-6; R 8和R 9连接在一起形成亚烷基; 在中枢5-HT1A受体上具有作用,并且可用于治疗精神病,焦虑症,抑郁症,冲动控制障碍,酒精滥用,侵略,缺血性疾病,由常规抗精神病药或心血管病引起的副作用。
Abstract:
The present invention relates to a compound of formula (I), wherein L is –C(O)NH-, -NHC(O)-, -S(O) 2 NH-, -NH- or -NHC(O)NH-; Ar is phenyl, benzyl, naphthyl or heteroaryl, selected from the group consisting of pyridinyl, pyrazolyl, pyrimidinyl, isoxazolyl or pyrazinyl, wherein Ar may be optionally substituted by one, two or three R 1 ; R 1 is hydrogen, lower alkyl, lower alkoxy, halogen, cyano, cycloalkyl, NHC(O)-lower alkyl, lower alkoxy substituted by halogen, lower alkyl substituted by halogen, or is phenyl optionally substituted by one or two halogen atoms, CF 3 O or lower alkyl, or is furanyl, thiazolyl or thiophenyl, optionally substituted by halogen or lower alkyl; X is CH or O; R is hydrogen or halogen; or a pharmaceutically suitable acid addition salt thereof, all racemic mixtures, all their corresponding enantiomers and/or optical isomers, which may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders, schizophrenia, neurological diseases, Parkinson's disease, neurodegenerative disorders, Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse, metabolic disorders, eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.
Abstract:
The present invention relates to novel pyrazole(thio) tetrahydronaphthyl carboxamides, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.
Abstract:
A curable resin comprising a compound having the structure (I): wherein each carbon 2, together with either its carbon 1 or carbon 3, are members of a fused cycloaliphatic ring, and when carbon 1 is a member of the ring so is N, and wherein each of the aliphatic or aromatic ring-member carbons may either be members of further fused cycloaliphatic rings or be bonded to a group selected from H or linear or branched C 1 to C 5 alkyl.
Abstract:
A diaromatic amine compound having the general formula (I): wherein R 1 , and R 2 together wirh the carbon atoms to which they are bonded are joined together to form a C 3 -C 30 ring, and R 3 is an ally!, benzyl, or methallyl group. R 4 , R 5 , and R 6 are independently hydrogen, C 1 -C 30 alkyl group, C 1 -C 30 alkenyl group, C 3 -C 12 cycloalkyl group, C 6 -C 25 aryl group, C 6 -C 25 arylalkyl group, or C 1 -C 30 alkoxy group.
Abstract:
Crosslinkable substituted fluorene compounds; oligomers and polymers prepared from such crosslinkable compounds; films and coatings; and multilayer electronic devices comprising such films are disclosed.